Synthomer Valuation

Q: What is the Fair Price of SYHM.Y when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

SYHM.Y ($3.77) is trading below our estimate of [[fair value]] ($9.51)

Is SYHM.Y undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SYHM.Y when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SYHM.Y ($3.77) is trading below our estimate of fair value ($9.51)

Significantly Below Fair Value: SYHM.Y is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SYHM.Y?

Key metric: As SYHM.Y is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for SYHM.Y. This is calculated by dividing SYHM.Y's market cap by their current revenue.
What is SYHM.Y's PS Ratio?
PS Ratio	0.1x
Sales	UK£1.97b
Market Cap	UK£279.70m

SYHM.Y key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.5x
Enterprise Value/EBITDA	12.9x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does SYHM.Y's PS Ratio compare to its peers?

The above table shows the PS ratio for SYHM.Y vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	0.9x
DNA Ginkgo Bioworks Holdings	1.7x	1.8%	US$354.3m
RYAM Rayonier Advanced Materials	0.4x	3.3%	US$584.7m
VHI Valhi	0.4x	n/a	US$750.4m
ECVT Ecovyst	1.4x	5.2%	US$932.1m
SYHM.Y Synthomer	0.1x	5.0%	US$279.7m

Price-To-Sales vs Peers: SYHM.Y is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (1.5x).

Price to Sales Ratio vs Industry

How does SYHM.Y's PS Ratio compare vs other companies in the US Chemicals Industry?

11 Companies	Price / Sales	Estimated Growth	Market Cap
Industry Avg.	1.4x	4.6%
SYHM.Y Synthomer	0.1x	5.0%	US$363.80m
TSE Trinseo	0.03x	5.0%	US$115.06m
ALTO Alto Ingredients	0.1x	3.1%	US$106.54m

11 Companies		Estimated Growth	Market Cap
Industry Avg.	1.4x	17.1%
SYHM.Y Synthomer	0.1x	85.4%	US$363.80m

No more companies

Price-To-Sales vs Industry: SYHM.Y is good value based on its Price-To-Sales Ratio (0.1x) compared to the US Chemicals industry average (1.4x).

Price to Sales Ratio vs Fair Ratio

What is SYHM.Y's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SYHM.Y PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.1x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate SYHM.Y's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Trinseo

US$115.1m

Operates as a specialty material solutions provider in the United States, Europe, the Asia-Pacific, and internationally.

TSE

US$3.46

-5.2%

-46.7%

Huntsman

US$3.4b

Manufactures and sells diversified organic chemical products worldwide.

HUN

US$19.62

1.7%

-21.3%

Chemtrade Logistics Income Fund

CA$1.4b

Offers industrial chemicals and services in Canada, the United States, and South America.

CGIF.F

CA$8.19

3.3%

29.8%